Robert G.  Finizio net worth and biography

Robert Finizio Biography and Net Worth

Robert G. Finizio has served as Chief Executive Officer and a director of our company since October 2011. As co-founder of VitaMedMD, LLC, or VitaMed, our wholly owned subsidiary, Mr. Finizio served as its Chief Executive Officer and a director from April 2008 to October 2011. Mr. Finizio has 16 years of successful early stage company development experience in the health care industry. Mr. Finizio co-founded and served from August 2001 to February 2008 as President of Care Fusion, LLC and then as Chief Executive Officer of CareFusion, Inc., a clinical technology vendor, which was acquired by Cardinal Health, Inc.

Mr. Finizio’s early business experience was with Omnicell, Inc. (formerly known as Omnicell Technologies, Inc.), a provider of pharmaceutical supply chain management systems and services, and Endoscopy Specialists, Inc. in the health care IT and surgical space. We believe Mr. Finizio’s intimate knowledge and experience with all aspects of the business, operations, opportunities, and challenges of our company and experience with early stage company development in the health care industry provide the requisite qualifications, skills, perspectives, and experience that make him well qualified to serve on our Board of Directors. Mr. Finizio earned a B.A. from the University of Miami.

What is Robert G. Finizio's net worth?

The estimated net worth of Robert G. Finizio is at least $21.31 million as of May 11th, 2021. Mr. Finizio owns 18,059,334 shares of TherapeuticsMD stock worth more than $21,310,014 as of December 17th. This net worth approximation does not reflect any other investments that Mr. Finizio may own. Additionally, Mr. Finizio receives a salary of $7,510.00 as CEO at TherapeuticsMD. Learn More about Robert G. Finizio's net worth.

How old is Robert G. Finizio?

Mr. Finizio is currently 53 years old. There are 3 older executives and no younger executives at TherapeuticsMD. The oldest executive at TherapeuticsMD is Governor Thomas G. Thompson, Executive Chairman, who is 82 years old. Learn More on Robert G. Finizio's age.

What is Robert G. Finizio's salary?

As the CEO of TherapeuticsMD, Inc., Mr. Finizio earns $7,510.00 per year. There are 3 executives that earn more than Mr. Finizio. The highest earning executive at TherapeuticsMD is Mr. Marlan D. Walker J.D., Chief Executive Officer, who commands a salary of $661,420.00 per year. Learn More on Robert G. Finizio's salary.

How do I contact Robert G. Finizio?

The corporate mailing address for Mr. Finizio and other TherapeuticsMD executives is 951 Yamato Road Suite 220, BOCA RATON FL, 33431. TherapeuticsMD can also be reached via phone at (561) 961-1900 and via email at [email protected]. Learn More on Robert G. Finizio's contact information.

Has Robert G. Finizio been buying or selling shares of TherapeuticsMD?

Robert G. Finizio has not been actively trading shares of TherapeuticsMD in the last ninety days. Most recently, Robert G. Finizio sold 67,697 shares of the business's stock in a transaction on Tuesday, May 11th. The shares were sold at an average price of $1.04, for a transaction totalling $70,404.88. Following the completion of the sale, the chief executive officer now directly owns 18,059,334 shares of the company's stock, valued at $18,781,707.36. Learn More on Robert G. Finizio's trading history.

Who are TherapeuticsMD's active insiders?

TherapeuticsMD's insider roster includes Paul Bisaro (Director), Edward Borkowski (EVP), Cooper Collins (Director), James D'Arecca (CFO), Michael Donegan (CAO), Robert Finizio (CEO), Tommy Thompson (Director), and Marlan Walker (General Counsel). Learn More on TherapeuticsMD's active insiders.

Are insiders buying or selling shares of TherapeuticsMD?

In the last twelve months, TherapeuticsMD insiders bought shares 1 times. They purchased a total of 1,200 shares worth more than $2,040.00. The most recent insider tranaction occured on August, 21st when Director Cooper C Collins bought 1,200 shares worth more than $2,040.00. Insiders at TherapeuticsMD own 2.3% of the company. Learn More about insider trades at TherapeuticsMD.

Information on this page was last updated on 8/21/2024.

Robert G. Finizio Insider Trading History at TherapeuticsMD

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/11/2021Sell67,697$1.04$70,404.8818,059,334View SEC Filing Icon  
6/5/2020Buy30,000$1.15$34,500.0018,335,964View SEC Filing Icon  
8/20/2019Buy35,000$2.74$95,900.0018,253,964View SEC Filing Icon  
8/9/2019Buy52,405$2.96$155,118.8018,166,559View SEC Filing Icon  
12/20/2018Sell184,910$3.66$676,770.6018,458,559View SEC Filing Icon  
12/7/2018Sell184,000$4.59$844,560.0018,366,559View SEC Filing Icon  
11/27/2018Sell184,000$4.83$888,720.0018,485,559View SEC Filing Icon  
11/13/2018Sell184,000$4.77$877,680.0018,485,559View SEC Filing Icon  
10/26/2018Sell184,000$5.28$971,520.0018,485,559View SEC Filing Icon  
10/11/2018Sell92,000$5.65$519,800.0018,485,559View SEC Filing Icon  
9/21/2018Sell184,000$6.63$1,219,920.0018,485,559View SEC Filing Icon  
9/7/2018Sell184,000$6.24$1,148,160.0018,485,559View SEC Filing Icon  
1/23/2014Sell50,000$5.70$285,000.00View SEC Filing Icon  
See Full Table

Robert G. Finizio Buying and Selling Activity at TherapeuticsMD

This chart shows Robert G Finizio's buying and selling at TherapeuticsMD by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

TherapeuticsMD Company Overview

TherapeuticsMD logo
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Read More

Today's Range

Now: $1.18
Low: $1.16
High: $1.21

50 Day Range

MA: $1.45
Low: $1.18
High: $1.62

2 Week Range

Now: $1.18
Low: $1.15
High: $2.75

Volume

15,634 shs

Average Volume

17,739 shs

Market Capitalization

$13.61 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.12